Bifidobacterium infantis Bifidobacterium infantis is a species commonly used in probiotic blends
Retatrutide and newer agents Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
The OpenLoop Healthcare Partners, PC relationship means there's an established medical group structure with documented telehealth consent, state licensure, and compliance infrastructure behind the clinical services - not just a website with a prescriber on call
GLP-1 RAs help by: Decreasing pro-inflammatory cytokine levels Reducing the Psoriasis Area Severity Index (PASI) Improving insulin sensitivity and reducing obesity (both of which exacerbate psoriasis) Wound Healing: In diabetic patients and others with chronic wounds, GLP-1 medications improve healing by: Reducing harmful MMP-9 levels and improving MMP-9/TIMP ratios Enhancing angiogenesis (new blood vessel formation) Normalizing C-reactive protein (CRP) levels, a marker of systemic inflammation Multi-System Anti-Inflammatory Effects of GLP-1 Medications GLP-1 agonists exhibit systemic anti-inflammatory effects across multiple organ systems: Cardiovascular: Reduces arterial plaque, improves endothelial function Renal: Protects glomeruli, reduces proteinuria, slows kidney disease progression Pulmonary: Reduces airway inflammation, potential benefits in asthma and COPD Liver (NAFLD/NASH): Lowers hepatic inflammation, improves liver enzymes GI/Metabolic: Reduces markers like IL-6 and CRP
Benefits include: Lower cost compared to surgery Little to no downtime No anesthesia or scarring Safe, in-office procedures Natural-looking results over time These options are particularly appealing for people looking to fine-tune their appearance after weight loss without the risks and recovery associated with more invasive procedures
doi: 10.7150/ijbs.27774 95
